ATLANTA–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a number one supplier of revolutionary, cloud-based healthcare expertise options, in the present day introduced its working outcomes for the fiscal fourth quarter and yr ended March 31, 2022.
Fiscal 2022 Fourth Quarter and Full Year Highlights
Total income for the fiscal 2022 fourth quarter was $151.3 million in comparison with $144.2 million for a similar interval a yr in the past, or 5% progress. Revenue for the fiscal yr ended March 31, 2022 was $596.4 million in comparison with $556.8 million a yr in the past.
Recurring income accounted for 91% of complete income within the fiscal 2022 fourth quarter, or $137.2 million, rising 6% over the yr in the past interval.
Subscription providers income within the fiscal 2022 fourth quarter generated $42.1 million, or 10% progress over the prior yr interval, pushed by demand for encompass options.
Fiscal 2022 fourth quarter bookings, which displays annual contract worth, was $41.4 million, a current file for the corporate, and displays progress of 18% over fiscal 2021 fourth quarter.
Fully diluted web earnings per share within the fiscal 2022 fourth quarter was $0.01 in comparison with web lack of $0.01 per share the identical interval a yr in the past. Fully diluted web earnings per share for fiscal yr 2022 was $0.02 in comparison with $0.14 per share a yr in the past.
On a non-GAAP foundation, absolutely diluted earnings per share for the fiscal 2022 fourth quarter was $0.19 in comparison with $0.21 for a similar interval a yr in the past. On a non-GAAP foundation, absolutely diluted earnings per share for fiscal yr 2022 was $0.98 in comparison with $0.98 reported a yr in the past.
“Fiscal fourth quarter displays one other robust efficiency pushed by broad demand for our options and the excessive stage of execution by our workforce. To higher place us for sooner income progress and working leverage, now we have accelerated the tempo of investments in strategic domains – Enterprise, Office and Insights,” mentioned David Sides, President and Chief Executive Officer of NextGen Healthcare. “We are devoted to our mission of advancing ambulatory care with improvements for more healthy communities and at our current investor occasion, we supplied a view into our thrilling future. The firm is on a transparent path to reveal accelerating income progress, and we look ahead to offering updates because the yr progresses.”
NextGen Healthcare confirms its fiscal yr 2023 income and non-GAAP earnings per share steerage and introduces an adjusted EBITDA vary for a similar interval. The Company’s fiscal yr 2023 monetary steerage is as follows:
Revenue of between $628 million and $640 million
Adjusted EBITDA of between $111 million and $116 million
Non-GAAP earnings per share of between $0.95 and $1.01
Conference Call Information
NextGen Healthcare will host a convention name in the present day at 5:00 p.m. EST to debate working outcomes from its fiscal 2022 fourth quarter and yr ended March 31, 2022. Shareholders and contributors could hearken to a stay broadcast of the decision by dialing 866-831-8713 or 203-518-9822 for worldwide callers and referencing participant code NXGNQ422 roughly quarter-hour previous to the decision. A recording of the stay webcast will likely be out there on investor.nextgen.com after the decision. It will likely be archived for 90 days.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press launch comprises forward-looking statements throughout the that means of the Private Securities Litigation Reform Act of 1995, together with however not restricted to statements we make concerning our fiscal yr 2023 outlook, monetary and working outcomes, strategic priorities, progress initiatives and anticipated capital expenditures. These forward-looking statements are primarily based on the present beliefs, expectations, and assumptions of the Company’s administration regarding the long run (together with, with out limitation, statements regarding income, web earnings, and earnings per share). The phrases “positioned,” “proposed,” “potential,” “mission,” “count on,” “anticipate,” “intend,” “plan,” “aim,” “search,” “imagine,” “estimate, “technique,” “expectations,” “future,” “doubtless,” “could,” “ought to,” “will,” variations thereof or comparable expressions are supposed to establish such forward-looking statements.
Risks and uncertainties exist that will trigger the outcomes to vary materially from these set forth in these forward-looking statements, together with however not restricted to: modifications in legal guidelines and laws relevant to our enterprise; modifications in market situations and receptivity to our providers and choices; strategic actions, together with acquisitions and inclinations and our success in integrating acquired companies; our capacity to keep up and broaden our enterprise with current shoppers or successfully transition shoppers to newer merchandise; our capacity to draw new companions and efficiently seize new alternatives; our capacity to develop and develop associate relationships; our capacity to draw and retain key staff; our capacity to anticipate or reply rapidly to market modifications, execute our technique and handle progress; the influence of litigation and governmental and regulatory company investigations; the influence of governmental and regulatory company investigations; the event by rivals of recent or superior applied sciences; the timing, price and success or failure of recent product and service introductions, growth and product improve releases; the influence of the COVID-19 pandemic on our operations and demand for our providers; influence of breaches or failures of the Company’s data safety measures or unauthorized entry to a buyer’s knowledge; disruptions brought on by acquisitions of corporations, merchandise, or applied sciences; and basic financial situations. Additional dialogue of those and different dangers, uncertainties and components affecting our enterprise is contained in our filings with the SEC, together with our most up-to-date Annual Report on Form 10-Ok and subsequently filed Quarterly Reports on Form 10-Q.
A good portion of the Company’s quarterly gross sales of software program product licenses and laptop {hardware} is concluded within the final month of a fiscal quarter, typically with a focus of such revenues earned within the last ten enterprise days of that month. Due to those and different components, the Company’s revenues and working outcomes are very tough to forecast. A significant portion of the Company’s prices and bills, akin to personnel and amenities, are of a hard and fast nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues sometimes ends in decrease profitability or losses. As a end result, comparability of the Company’s period-to-period monetary efficiency is just not essentially significant and shouldn’t be relied upon as an indicator of future efficiency. These forward-looking statements converse solely as of the date hereof. The Company undertakes no obligation to publicly replace any forward-looking statements, whether or not because of new data, future occasions or in any other case.
USE OF NON-GAAP FINANCIAL MEASURES
This information launch comprises sure non-GAAP (Generally Accepted Accounting Principles) monetary measures, that are supplied solely as supplemental data. Investors ought to contemplate these non-GAAP monetary measures solely along with the comparable GAAP monetary measures. These non-GAAP measures usually are not in accordance with or an alternative to U.S. GAAP. Pursuant to the necessities of Regulation G, the Company has supplied a reconciliation of non-GAAP monetary measures to essentially the most straight comparable monetary measure within the accompanying monetary tables. Other corporations could calculate non-GAAP measures in another way than NextGen Healthcare, Inc., which limits comparability between corporations. The Company believes that its presentation of non-GAAP diluted earnings per share offers helpful supplemental data to buyers and administration concerning the Company’s monetary situation and outcomes. The presentation of non-GAAP monetary data is just not supposed to be thought-about in isolation or as an alternative to, or superior to, monetary data ready and offered in accordance with GAAP.
The Company calculates non-GAAP diluted earnings per share by excluding web acquisition prices, amortization of acquired intangible property, amortization of deferred debt issuance prices, impairment of property, restructuring prices, shareholder disputes and associated prices, web of insurance coverage, which embody web securities litigation protection, proxy contest, and associated prices, share-based compensation, and different non-run-rate bills from GAAP earnings earlier than provision for earnings taxes.
The Company makes use of a normalized non-GAAP tax fee to supply higher consistency throughout the interim reporting intervals inside a given fiscal yr by eliminating the consequences of non-recurring and period-specific gadgets, which might fluctuate in measurement and frequency, and which aren’t essentially reflective of the Company’s longer-term operations. The normalized non-GAAP tax fee utilized to every quarter of fiscal yr 2022 was 20.0%. The dedication of this fee relies on the consideration of each historic and projected monetary outcomes. The Company could alter its non-GAAP tax fee as further data turns into out there and along with every other important occasions happen that will materially have an effect on this fee, akin to merger and acquisition exercise, modifications in enterprise outlook, or different modifications in expectations concerning tax laws.
The Company calculates free money stream as complete web money supplied by working actions, web of money used for the additions of capitalized software program prices and tools and enhancements. The Company calculates web debt as line of credit score much less money and money equivalents. The Company calculates non-GAAP adjusted EBITDA by excluding web acquisition prices, amortization of acquired intangible property, impairment of property, restructuring prices, shareholder disputes and associated prices, web of insurance coverage, which embody web securities litigation protection, proxy contest, and associated prices, share-based compensation, and different non-run-rate bills from GAAP earnings from operations and then including again amortization of capitalized software program prices and depreciation as offered throughout the condensed consolidated statements of money flows. Non-GAAP adjusted EBITDA margin is calculated as non-GAAP adjusted EBITDA divided by complete revenues. The Company calculates Rule of 40 as annual income progress fee plus non-GAAP adjusted EBITDA margin.
The Company’s future interval steerage on this launch contains changes for gadgets not indicative of the Company’s core operations. Such changes are typically anticipated to be of a nature just like these changes utilized to the Company’s historic GAAP monetary ends in the dedication of the Company’s non-GAAP diluted earnings per share. Such changes, nonetheless, could also be affected by modifications in ongoing assumptions and judgments as to the gadgets which are excluded within the calculation of non-GAAP adjusted web earnings and adjusted diluted earnings per share, as described on this launch. The precise quantity and possible significance of those changes, together with web acquisition prices, impairment of property, restructuring prices, shareholder disputes and associated prices, which embody web securities litigation protection, proxy contest, and associated prices, and different non-run-rate bills, usually are not at the moment determinable with out unreasonable efforts, however could also be important. These gadgets can’t be reliably quantified or forecasted because of the mixture of their historic and anticipated variability. It is due to this fact not practicable to reconcile this non-GAAP steerage to essentially the most comparable GAAP measures.
About NextGen Healthcare, Inc.
NextGen Healthcare, Inc. (Nasdaq: NXGN) is a number one supplier of revolutionary expertise options. We are reimagining ambulatory healthcare with award-winning options that allow high-performing practices to create more healthy communities. We associate with medical, behavioral and dental suppliers of their journey towards entire individual well being and value-based care. Our extremely built-in, clever and interoperable options transcend EHR and Practice Management to extend scientific high quality and productiveness, enrich the affected person expertise and drive superior monetary efficiency. We are on a quest to attain higher healthcare outcomes for all. Learn extra at nextgen.com, and comply with us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
NEXTGEN HEALTHCARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In hundreds, besides per share knowledge)
(Unaudited)
Three Months
Ended March 31,
Fiscal Year
Ended March 31,
2022
2021
2022
2021
Revenues:
Recurring
$
137,227
$
129,363
$
539,713
$
502,819
Software, {hardware}, and different non-recurring
14,032
14,825
56,637
54,002
Total revenues
151,259
144,188
596,350
556,821
Cost of income:
Recurring
60,169
54,660
232,481
212,199
Software, {hardware}, and different non-recurring
7,949
7,533
31,034
26,457
Amortization of capitalized software program prices and acquired intangible property
7,643
7,588
31,889
36,768
Total price of income
75,761
69,781
295,404
275,424
Gross revenue
75,498
74,407
300,946
281,397
Operating bills:
Selling, basic and administrative
50,046
48,870
209,661
180,529
Research and growth prices, web
19,428
21,390
76,657
75,501
Amortization of acquired intangible property
882
1,113
3,525
4,449
Impairment of property
2,329
3,324
3,906
5,539
Restructuring prices
—
—
539
2,562
Total working bills
72,685
74,697
294,288
268,580
Income (loss) from operations
2,813
(290
)
6,658
12,817
Interest earnings
22
11
101
38
Interest expense
(541
)
(643
)
(1,499
)
(3,516
)
Other expense, web
(21
)
(47
)
(64
)
(64
)
Income (loss) earlier than provision for (advantage of) earnings taxes
2,273
(969
)
5,196
9,275
Provision for (advantage of) earnings taxes
1,925
(389
)
3,578
(240
)
Net earnings (loss):
$
348
$
(580
)
$
1,618
$
9,515
Net earnings (loss) per share:
Basic
$
0.01
$
(0.01
)
$
0.02
$
0.14
Diluted
$
0.01
$
(0.01
)
$
0.02
$
0.14
Weighted-average shares excellent:
Basic
66,929
67,029
67,370
66,739
Diluted
67,547
67,919
67,788
66,885
NEXTGEN HEALTHCARE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In hundreds, besides per share knowledge)
(Unaudited)
March 31, 2022
March 31, 2021
ASSETS
Current property:
Cash and money equivalents
$
59,829
$
73,295
Restricted money and money equivalents
6,918
5,280
Accounts receivable, web
76,057
77,541
Contract property
25,157
19,481
Income taxes receivable
6,507
765
Prepaid bills and different present property
37,102
31,282
Total present property
211,570
207,644
Equipment and enhancements, web
9,120
14,539
Capitalized software program prices, web
43,958
41,474
Operating lease property
11,316
18,446
Deferred earnings taxes, web
19,259
19,474
Contract property, web of present
1,910
1,976
Intangibles, web
24,303
36,700
Goodwill
267,212
267,212
Other property
39,026
37,021
Total property
$
627,674
$
644,486
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
9,125
$
11,378
Contract liabilities
61,280
52,863
Accrued compensation and associated advantages
48,736
50,374
Income taxes payable
99
584
Operating lease liabilities
8,089
12,735
Other present liabilities
53,533
52,699
Total present liabilities
180,862
180,633
Deferred compensation
7,230
6,620
Operating lease liabilities, web of present
11,934
18,453
Other noncurrent liabilities
4,570
7,136
Total liabilities
204,596
212,842
Commitments and contingencies
Shareholders’ fairness:
Common inventory, $0.01 par worth; licensed 100,000 shares; 69,245 and 67,069 shares issued at March 31, 2022 and March 31, 2021, respectively; 67,075 and 67,069 shares excellent at March 31, 2022 and March 31, 2021, respectively
692
671
Treasury inventory, at price, 2,170 shares at March 31, 2022
(35,874
)
—
Additional paid-in capital
329,917
304,263
Accumulated different complete loss
(1,909
)
(1,924
)
Retained earnings
130,252
128,634
Total shareholders’ fairness
423,078
431,644
Total liabilities and shareholders’ fairness
$
627,674
$
644,486
NEXTGEN HEALTHCARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In hundreds)
(Unaudited)
Three Months
Ended March 31,
Fiscal Year
Ended March 31,
2022
2021
2022
2021
Cash flows from working actions:
Net earnings (loss)
$
348
$
(580
)
$
1,618
$
9,515
Adjustments to reconcile web earnings to web money supplied by working actions:
Amortization of capitalized software program prices
5,424
5,280
23,016
20,108
Amortization and write-off of debt issuance prices
127
494
508
1,026
Amortization of different intangibles
3,099
3,421
12,397
21,109
Change in honest worth of contingent consideration
—
(1,442
)
7
(1,367
)
Deferred earnings taxes
180
(8,812
)
215
(8,854
)
Depreciation
1,496
1,909
6,902
7,997
Excess tax deficiency (profit) from share-based compensation
(191
)
(72
)
643
798
Impairment of property
2,329
3,324
3,906
5,539
Loss on disposal of kit and enhancements
20
(15
)
97
12
Non-cash working lease prices
1,277
1,633
5,732
6,786
Provision for dangerous money owed
773
790
1,915
2,834
Share-based compensation
7,867
5,947
26,552
22,710
Changes in property and liabilities:
Accounts receivable
(6,750
)
(1,590
)
(431
)
(369
)
Contract property
(824
)
(1,863
)
(5,610
)
(5,921
)
Accounts payable
(5,921
)
3,410
(2,329
)
615
Contract liabilities
6,401
4,208
8,417
(3,923
)
Accrued compensation and associated advantages
6,717
10,372
(1,638
)
26,582
Income taxes
1,564
5,109
(5,650
)
1,615
Deferred compensation
(441
)
(4
)
610
1,320
Operating lease liabilities
(2,672
)
(6,693
)
(12,734
)
(16,736
)
Other property and liabilities
(3,914
)
(2,286
)
(10,598
)
7,122
Net money supplied by working actions
16,909
22,540
53,545
98,518
Cash flows from investing actions:
Additions to capitalized software program prices
(7,663
)
(5,664
)
(25,500
)
(24,578
)
Additions to tools and enhancements
(545
)
(2,215
)
(2,582
)
(3,761
)
Acquisition associated working capital adjustment funds
—
—
—
(206
)
Net money utilized in investing actions
(8,208
)
(7,879
)
(28,082
)
(28,545
)
Cash flows from financing actions:
Proceeds from line of credit score
—
—
—
50,000
Repayments on line of credit score
—
(29,000
)
—
(179,000
)
Payment of debt issuance prices
—
(1,423
)
—
(1,423
)
Payment of contingent consideration associated to acquisitions
—
—
(540
)
—
Proceeds from issuance of shares underneath worker plans
4,137
1,482
5,014
3,479
Repurchase of widespread inventory
—
—
(35,874
)
—
Payments for taxes associated to web share settlement of fairness awards
(441
)
(876
)
(5,891
)
(4,773
)
Net money supplied by (utilized in) financing actions
3,696
(29,817
)
(37,291
)
(131,717
)
Net enhance (lower) in money, money equivalents, and restricted money
12,397
(15,156
)
(11,828
)
(61,744
)
Cash, money equivalents, and restricted money at starting of interval
54,350
93,731
78,575
140,319
Cash, money equivalents, and restricted money at finish of interval
$
66,747
$
78,575
$
66,747
$
78,575
NEXTGEN HEALTHCARE, INC.
SUPPLEMENTAL FINANCIAL INFORMATION
(In hundreds)
The following desk presents our revenues disaggregated by our main income classes and by incidence:
Three Months
Ended March 31,
Fiscal Year
Ended March 31,
2022
2021
2022
2021
Recurring revenues:
Subscription providers
$
42,055
$
38,218
$
162,636
$
148,403
Support and upkeep
39,887
38,419
155,623
152,956
Managed providers
28,924
27,032
116,722
103,138
Electronic knowledge interchange and knowledge providers
26,361
25,694
104,732
98,322
Total recurring revenues
137,227
129,363
539,713
502,819
Software, {hardware}, and different non-recurring revenues:
Software license and {hardware}
7,145
8,163
31,347
28,825
Other non-recurring providers
6,887
6,662
25,290
25,177
Total software program, {hardware} and different non-recurring revenues
14,032
14,825
56,637
54,002
Total revenues
$
151,259
$
144,188
$
596,350
$
556,821
Recurring revenues as a proportion of complete revenues
90.7
%
89.7
%
90.5
%
90.3
%
NEXTGEN HEALTHCARE, INC.
NON-GAAP FINANCIAL MEASURES
(In hundreds, besides per share knowledge)
RECONCILIATION OF NON-GAAP DILUTED EARNINGS PER SHARE
Three Months
Ended March 31,
Fiscal Year
Ended March 31,
2022
2021
2022
2021
Income earlier than provision for earnings taxes – GAAP
$
2,273
$
(969
)
$
5,196
$
9,275
Non-GAAP changes:
Acquisition prices, web
—
(1,409
)
—
(1,029
)
Amortization of acquired intangible property
3,099
3,421
12,397
21,109
Amortization of deferred debt issuance prices
127
494
508
1,026
Impairment of property
2,329
3,324
3,906
5,539
Restructuring prices
—
—
539
2,562
Shareholder disputes and associated prices, web of insurance coverage
531
6,060
29,747
16,274
Share-based compensation
7,867
5,947
26,552
22,710
Other non-run-rate bills*
107
620
4,486
4,754
Total changes to GAAP earnings earlier than provision for earnings taxes:
14,060
18,457
78,135
72,945
Income earlier than provision for earnings taxes – Non-GAAP
16,333
17,488
83,331
82,220
Provision for earnings taxes
3,266
3,498
16,666
16,444
Net earnings – Non-GAAP
$
13,067
$
13,990
$
66,665
$
65,776
Diluted web earnings per share – Non-GAAP
$
0.19
$
0.21
$
0.98
$
0.98
Weighted-average shares excellent (diluted):
67,547
67,919
67,788
66,885
* Other non-run-rate bills for the three months ended March 31, 2022 encompass $107 extra lease-related expense for vacated amenities.
Other non-run-rate bills for the three months ended March 31, 2021 consist primarily of $552 extra lease-related expense for vacated amenities, lease termination prices, and different prices, together with retention bonuses and severance expense, associated to the restructuring plan and $68 {of professional} providers prices not associated to core operations.
Other non-run-rate bills for the yr ended March 31, 2022 consist primarily of $1,242 extra lease-related expense for vacated amenities, lease termination prices, and different prices, together with retention bonuses, associated to the restructuring plan and $2,707 of govt transition prices, together with severance and different prices associated to the departure of the CEO, $498 of incremental prices and penalties primarily because of the cancellation of sure occasions straight related to the COVID-19 pandemic, and $39 {of professional} providers prices not associated to core operations.
Other non-run-rate bills for the yr ended March 31, 2021 consist primarily of $3,183 extra lease-related expense for vacated amenities, lease termination prices, and different prices, together with retention bonuses and severance expense, associated to the restructuring plan, $1,472 {of professional} providers prices not associated to core operations, and $99 of incremental prices and penalties primarily because of the cancellation of sure occasions straight related to the COVID-19 pandemic.
RECONCILIATION OF FREE CASH FLOW
Three Months
Ended March 31,
Fiscal Year
Ended March 31,
2022
2021
2022
2021
Net money supplied by working actions
$
16,909
$
22,540
$
53,545
$
98,518
Additions to capitalized software program prices
(7,663
)
(5,664
)
(25,500
)
(24,578
)
Additions to tools and enhancements
(545
)
(2,215
)
(2,582
)
(3,761
)
Free money stream
$
8,701
$
14,661
$
25,463
$
70,179
NEXTGEN HEALTHCARE, INC.
NON-GAAP FINANCIAL MEASURES
(In hundreds)
RECONCILIATION OF ADJUSTED EBITDA
Three Months
Ended March 31,
Fiscal Year
Ended March 31,
2022
2021
2022
2021
Income (loss) from operations – GAAP
$
2,813
$
(290
)
$
6,658
$
12,817
Non-GAAP changes:
Acquisition prices, web
—
(1,409
)
—
(1,029
)
Amortization of acquired intangible property
3,099
3,421
12,397
21,109
Impairment of property
2,329
3,324
3,906
5,539
Restructuring prices
—
—
539
2,562
Shareholder disputes and associated prices, web of insurance coverage
531
6,060
29,747
16,274
Share-based compensation
7,867
5,947
26,552
22,710
Other non-run-rate bills*
107
620
4,486
4,754
Total changes to GAAP earnings (loss) from operations:
13,933
17,963
77,627
71,919
Income from operations – Non-GAAP
16,746
17,673
84,285
84,736
Amortization of capitalized software program prices
5,424
5,280
23,016
20,108
Depreciation
1,496
1,909
6,902
7,997
Depreciation and Amortization – Non-GAAP
6,920
7,189
29,918
28,105
Adjusted EBITDA – Non-GAAP
$
23,666
$
24,862
$
114,203
$
112,841
Total revenues
$
151,259
$
144,188
$
596,350
$
556,821
Adjusted EBITDA margin – Non-GAAP
15.6
%
17.2
%
19.2
%
20.3
%
* Other non-run-rate bills for the three months ended March 31, 2022 encompass $107 extra lease-related expense for vacated amenities.
Other non-run-rate bills for the three months ended March 31, 2021 consist primarily of $552 extra lease-related expense for vacated amenities, lease termination prices, and different prices, together with retention bonuses and severance expense, associated to the restructuring plan and $68 {of professional} providers prices not associated to core operations.
Other non-run-rate bills for the yr ended March 31, 2022 consist primarily of $1,242 extra lease-related expense for vacated amenities, lease termination prices, and different prices, together with retention bonuses, associated to the restructuring plan and $2,707 of govt transition prices, together with severance and different prices associated to the departure of the CEO, $498 of incremental prices and penalties primarily because of the cancellation of sure occasions straight related to the COVID-19 pandemic, and $39 {of professional} providers prices not associated to core operations.
Other non-run-rate bills for the yr ended March 31, 2021 consist primarily of $3,183 extra lease-related expense for vacated amenities, lease termination prices, and different prices, together with retention bonuses and severance expense, associated to the restructuring plan, $1,472 {of professional} providers prices not associated to core operations, and $99 of incremental prices and penalties primarily because of the cancellation of sure occasions straight related to the COVID-19 pandemic.
A reconciliation of adjusted EBITDA for every interim reporting interval throughout the fiscal years ended March 31, 2022 and 2021 could also be accessed via our Investor Relations web site at http://investor.nextgen.com.
https://www.businesswire.com/news/home/20220517005950/en/NextGen-Healthcare-Reports-Fiscal-2022-Fourth-Quarter-and-Full-Year-Results
